Previous close | 0.4851 |
Open | 0.4787 |
Bid | 0.5074 x 400 |
Ask | 0.5158 x 300 |
Day's range | 0.4701 - 0.5291 |
52-week range | 0.2900 - 1.7800 |
Volume | |
Avg. volume | 2,386,271 |
Market cap | 104.176M |
Beta (5Y monthly) | 1.35 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings date | 24 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.50 |
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
Sangamo Therapeutics ( NASDAQ:SGMO ) Full Year 2023 Results Key Financial Results Revenue: US$176.2m (up 58% from FY...